List of Top 50 Cited Publications

Publications Diagnosis Year Published # of Citations
Resnick L, DiMarzo-Veronese F, Schupbach J, Tourtellotte WW, Ho DD, Muller R, Shapshak P, Vogt M, Groopman JE, Markham PD and Gallo RC: Intra-Blood-Brain-Barrier Synthesis of HTLV-III Specific IgG in Patients with Neurologic symptoms Associated with AIDS or AIDS-Related Complex. New Engl J Med 313: 1498-1504, 1985. AIDS 1985 916
Rothstein JD, Martin LJ and Kuncl RW: Decreased Glutamate Transport by the Brain and Spinal Cord in Amyotrophic Lateral Sclerosis. New Eng J Med 326(22): 1464-1468, 1992. Amyotrophic Lateral Sclerosis 1992 576
Hofman FM, Hinton DR, Johnson K and Merrill JE: Tumor Necrosis Factor Identified in Multiple Sclerosis Plaques. Journal of Experimental Medicine 17 (2): 607-612, 1989. Multiple Sclerosis 1989 529
Seeman P, Guan HC and Van Tol HHM : Dopamine D4 receptors elevated in Schizophrenia. Nature 365: 441-445, 1993. Schizophrenia 1993 486
Blum K, Noble EP, Sheridan PJ, Montgomery A, Ritchie T, Jagadeeswaran P, Nogami H, Briggs AH and Cohn JB: Allelic Association of Human Dopamine D2 Receptor Gene in Alcoholism. JAMA 263: 2055-2060, 1990. Alcohol Abuse 1990 443
Pestronk A, Cornblath DR, Ilyas AA, Baba H, Quarles RH, Griffin JW, Alderson K and Adams RN: A treatable multifocal motor neuropathy with antibodies to GM1 ganglisode. Annals of Neurology 24: 73-78, 1988. Neuropathy 1988 404
Phillips HS, Hains JM, Laramee GR,; Rosenthal A and Winslow JW: Widespread Expression of BDNF but not NT3 by Target Areas of Basal Forebrain cholinergic neurons. Science 250: 393-294, 1990. Biochemistry 1990 378
Akbarian S, Bunney WE Jr,; Potkin SG, Wigal SB, Hagman JO, Sandman CA and Jones EG: Altered Distribution of Nicotinamide-Adenine Dinucleotide Phosphate-Diaphorase Cells in Frontal Lobe of Schizophrenics Implies Disturbances of Cortical Development. Arch Gen Psych 50: 169-177, 1993. Schizophrenia 1993 365
Chou DKH, Ilyas AA, Evans JE, Costello C,; Quarles RH and Jungawala FB: Structure of sulfated gucuronyl glycolipids in the nervous system reacting with HNK-1 antibody and some IgM paraproteins in neuropathy. J Biol Chem 26 (25): 11717-11725, 1986. Neuropathy 1986 350
Bo L, Dawson TM, Wesselingh S, Mork S, Choi S, Kong PA, Hanley D and Trapp BD: Induction of Nitric Oxide Synthase in Demyelinating Regions of Multiple Sclerosis Brains. Annals of Neurology 36(5): 778-786, 1994. Multiple Sclerosis 1994 341
Houser CR, Miyashiro JE, Swartz BE, Walsh GO, Rich JR and Delgado-Escueta AV: Altered Patterns of Dymorphin Immunoreactivity suggest Mossy Fiber Reorganization in Human Hippocampal Epilepsy. J Neurosci 10(1): 267-282, 1990. Epilepsy 1990 324
Sobel RA, Mitchell ME and Fondren G: Intercellular Adhesion Molecule-1 (ICAM-1) in Cellular Immune Reactions in the Human Central Nervous System. Am J Path 136:1309-1316, 1990. Biochemistry 1990 311
Reiner A, Albin RL, Anderson KD, D’Amato CJ, Penney JB and Young AB: Differential loss of striatal projection neurons in Huntington’s Disease.Proc Natl Acad Sci USA 85: 5733-5737, 1988. Huntington’s Disease 1988 306
Akbarian S, Akbarian S, Vinuela A, Kim JJ, Potkin SG, Bunney WE Jr and Jones EG: Distorted Distribution of Nicotinamide-Adenine Dinucleotide Phosphate-Diaphorase Neurons in Temporal Lobe of Schizophrenics Implies Anomalous Cortical Development. Arch Gen Psych 50: 178-187, 1993. Schizophrenia 1993 299
Comings DE, Comings BG, Muhleman D, Dietz G, Shahbahrami B, Tast D, Knell E, Kocsis P, Baumgarten R, Kovacs BW, Levy DL, Smith M, Borison RL, Evans DD, Klein DN, MacMurray J, Tosk JM, Sverd J, Bysin R and Flanagan SD: The Dopamine D2 Receptor Locus as a Modifying Gene in Neuropsychiatric Disorders. JAMA 266: 1793-1800, 1991. Alcohol Abuse 1991 296
Yan SD, Chen X, Schmidt A M, Brett J, Godman G, Zou YS, Scott CW, Caputo C, Frappier T, Smith M.A, Perry G, Yen SH and Stern D: Glycated tau protein in Alzheimer disease:A mechanism for induction of oxidant stress. Proc Natl Acad Sci USA 91: 7787-7791, 1994. Alzheimer’s Disease 1994 296
Akbarian S, Kim JJ, Potkin SG, Hageman JO, Tafazzoli A, Bunney WE and Jones EG: Gene Expression for Glutamic Acid Decarboxylase in Reduced Without Loss of Neurons in Prefrontal Cortex of Schizophrenics. Arch Gen Psych 52: 258-266, 1995. Schizophrenia 1995 292
Challoner PB, Smith KT, Parker J.D, MacLeod DL, Coulter SN, Rose TM, Schultz ER, Bennet JL, Garber RL, Chang M, Schad PA, Stewart PM, Nowinskin RC, Brown JP and Burmer GC: Plaque-Associated Expression of Human Herpes virus 6 in Multiple Sclerosis. Proc Natl Acad Sci USA 92(16): 7440-7444, 1995. Multiple Sclerosis 1995 280
Rothstein JD, Tsai G, Kuncl RW, Clawson L, Cornblath DR, Drachman DB, Pestronk A,; Stauch BL and Coyle JT: Abnormal Excitatory Amino acid Metabolism in Amyotrophic Lateral Sclerosis. Annals of Neurology 28(1): 18-25, 1990. Amyotrophic Lateral Sclerosis 1990 270
Iacopino AM and Christakos S: Specific reduction of calcium-binding protein (28-kilodalton calbindin D) gene expression in aging and neurodegenerative diseases. Proc Natl Acad Sci USA 87: 4078-4082, 1990. Biochemistry 1990 254
Phillips HS, Hains JM, Armanini M, Laramee GR,; Johnson SA and Winslow JW: BDNF mRNA is decreased in the Hippocampus of individuals with Alzheimer’s Disease. Neurology 7: 695-702, 1991. Alzheimer’s Disease 1991 247
Resnick L, Berger JR, Shapshak P and Tourtellotte WW: Early penetration of the blood-brain-barrier by HIV. Neurology 38(1): 9-14, 1988. AIDS 1988 245
Noble EP, Blum I, Ritchie T, Montgomery A and Sheridan PJ: Allelic Association of the D2 Dopamine Receptor Gene with Receptor-Binding characteristics in Alcoholism. Arch Gen Psych 48: 648-654, 1991. Alcohol Abuse 1991 242
Duguid JR, Rohwer RG and Seed B: Isolation of cDNAs of scrapie-modulated RNAs by subtractive hybridization of a cDNA library. Proc Natl Acad Sci USA 85(15): 5738-5742, 1988. Biochemistry 1988 238
Heyes MP, Saito K, Crowley SJ, davis LE, Demitrack MA, Der M, Dilling LA, Elia J, Krusei MJ, Lackner A et al: Quinolinic Acid and Kynurenine Pathway Metabolism in Inflammatory and Non inflammatory Neurologic Disease. Brain 115(5): 1249-1273, 1992. Biochemistry 1992 230
Bagasra O, Lavi E, Bobroski L, Khalili K, Pestaner JP, Tawadros R and Pomerantz RJ: Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: Identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 10(6): 573-585, 1985. HIV (+) 1996 223
Gelbard HA, Notte HSLM, Swindells S, Jett m, Dzenko KA, Genis P, White R, Wang L, Choi YB, Zhang D, Lipton SA,; Tourtellotte WW, Epstein LG and Gendelman HE: Platelet-Activating Factor: a candidate Human Immunodeficiency Virus Type 1 – Induced Neurotoxin. Journal of Virology 68(7): 4628-4635, 1994. AIDS 1994 210
Seeman P, Guan HC and Niznik HB: Endogenous Dopamine Lowers the Dopamine D2 Receptor Density as Measured by [3H]Raclopride: Implications for Positron Emission Tomography of the Human Brain. Synapse 3: 96-97, 1989. Schizophrenia 1989 208
Ritvo ER, Freeman BJ, Scheibel AB, Duong PT, Robinson H, Guthrie D and Ritvo A: Lower Purkinje cell counts in the cerebella of four autistic subjects: initial findings of the UCLA-NSAC Autopsy Research Report. [Case Reports]. American Journal of Psychiatry. 143(7): 862-6, 1986. Autism 1986 205
Selmaj K, Brosnan CF and Raine SR: Colocalization of lymphocytes bearing gd T-cell receptor and heat shock protein hsp65+ oligodendrocytes in multiple sclerosis. Proc Natl Acad Sci USA 88: 6452-5456, 1991. Multiple Sclerosis 1991 204
Chou KH, Ilyas AA, Evans JE, Quarles RH and Jungalwala FB: Structure of a Glycolipid Reactin with Monoclonal IgM in Neuropathy and with HNK-1. Biochem, Biophys, Res Comm. 128(1): 383-388, 1985. Neuropathy 1985 197
Dowling P, Shang G, Raval S, Menonna J, Cook S and Husar W: Involvement of the CD95(APO-1/Fas) Receptor/Ligand System in Multiple Sclerosis Brain. Journal of Experimental Medicine 184:1513-1518, 1996. Multiple Sclerosis 1996 195
Adams JD and Odunze IN: Oxygen Free Radicals and Parkinson’s Disease. Free Radical Biology & Med. 10: 161-169, 1991. Parkinson’s Disease 1991 191
Flynn DD and Mash DC: Characterization of L-[3H] Nicotine binding in human cerebral cortex: Comparison between Alzheimer’s disease and the normal. J Neurochem 47:1948-1954, 1986. Alzheimer’s Disease 1986 189
Ilyas AA , Willison HJ, Quarles RH, Jungalwala FB, Cornblath DR, Trapp BD, Griffin DE and McKhann GM: Serum antibodies to gangliosdies in Guillain-Barre syndrome. Annals of Neurology 23: 440-447, 1988. Guillian Barre 1988 181
Seeman P and Niznik HB: Dopamine receptors and transporters in Parkinson’s disease and schizophrenia. FASEB J 4: 2737-2744, 1990. Parkinson’s Disease 1990 176
Seeman P, Bzowej NH, Guan HC, Bergeron C, Becker LE, Reynolds GP, Bird ED, Riederer P, Jellinger K, Watanabe S and Tourtellotte WW: Human Brain Dopamine Receptors in Children and Aging Adults. Synapse 1: 399-404, 1987. Biochemistry 1987 172
Yan S D, Yan S F, Chen X, Fu J, Chen M, Kuppusamy P, Smith M A, Perry G, Godman G C, Nawroth P, Zweier J L and Stern D: Non-enzymatically glycated tau in Alzheimer’s disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid ß-peptide. Nature Medicine (7): 693-699, 1995. Alzheimer’s Disease 1995 166
Maeda A and Sobel RA: Matrix metalloproteinases in the normal human central nervous system, microglial nodules and multiple sclerosis lesions. J Neuropathol Exp Neuro 55: 300-309, 1996. Multiple Sclerosis 1996 158
Kaufman MJ and Madras BK: Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson’s Diseased striatum. Synapse 9: 43-49, 1991. Parkinson’s Disease 1991 155
Singer HS, Hahn IH and Moran TH: Abnormal Dopamine Uptake Sites in Postmortem Striatum from Patients with Tourette’s Syndrome. Annals of Neurology 30: 558-562, 1991. Tourette’s Syndrome 1991 153
Freedman R, Hall M, Adler L E and Leonard S: Evidence in Postmortem Brain Tissue for Decreased Numbers of Hippocampal Nicotinic Receptors in Schizophrenia. Biol Psychiatry 38: 22-33, 1995. Schizophrenia 1995 153
Gong CX, Singh TJ, Grundke-Iqbal I and Iqbal K: Phosphoprotein phosphatase activities in Alzheimer disease brain. J Neurochem 61: 921-927, 1993. Alzheimer’s Disease 1993 152
Alonso AD, del C, Zaidi T, Grundke-Iqbal I and Iqbal K: Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc Natl Acad Sci USA 91: 5562-5566, 1994. Alzheimer’s Disease 1994 152
Teller JK, Russo C, DeBusk LM, Angelini G, Zaccheo D, Dagna-Bricarelli F, Scartezzini P, Bertolini S, Mann DM, Tabaton M and Bambetti P: Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down’s syndrome. Nature Medicine 2(1): 93-95, 1996. Down’s Syndrome 1996 151
Telenius h, Kremer B, Goldberg YP, Theilmann J, Andrew SE. Zeisler J, Adam S, Greenberg C, Ives EJ, Clarke LA and Michael R Hayden: Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm. Nature Genetics 6: 409-414, 1994. Huntington’s Disease 1994 151
Akbarian S, Sucher NJ, Bradley D, Tafazzoli A, Trink D, Hetrick WP, Potkin SG, Sandman CA, Bunney WE and Jones EG: Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J Neurosci 16: 19-30, 1996. Schizophrenia 1996 151
Impagnatiello F, Guidotti AR, Pesold C, Dwivedi Y, Caruncho H, Pisu MG, Uzunov DP, Smalheiser NR, Davis JM; Pandey GN, Pappas GD, Tueting P, Sharma RP and Costa E: A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci USA 95:15718-15723, 1998. Schizophrenia 1998 151